The Blue Venture Fund
The Blue Venture Fund is a healthcare-focused strategic venture capital platform owned and capitalized by 32 Blue Cross Blue Shield plans, investing from seed to buyout across healthcare technology, services, and clinical sciences while providing portfolio companies privileged distribution access to 115 million covered lives.
- Company typePrivate
- Founded2008
- HeadquartersChicago, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What The Blue Venture Fund does
The Blue Venture Fund (legal entity: BlueCross BlueShield Venture Partners, L.P.) is a healthcare-focused strategic venture capital platform founded in 2010 and headquartered in Chicago. It is uniquely structured as a partnership among 32 participating Blue Cross Blue Shield companies and affiliates, the Blue Cross Blue Shield Association, and Sandbox Industries (which serves as the independent investment manager). The fund invests stage-agnostically — from seed to growth to buyout — across three verticals: Healthcare Technology, Healthcare Services, and Clinical Sciences. As of 12/31/2024, BVF reported 80+ investments made, 37 active portfolio companies, and 30 realized exits.
The fund's core commercial proposition is its BVF Platform, which connects portfolio companies directly with Blue Plan decision-makers and subject-matter experts across a network of 1,000+ Blue Cross Blue Shield leaders. This platform has produced 270+ contracts between current and former portfolio companies and Blue Plans, functioning as a structural go-to-market accelerator that distinguishes BVF from independent healthcare VCs. Portfolio companies span behavioral health (Big Health, Owl Insights), women's health (Origin), cancer care (Daymark Health), cardiac diagnostics (HeartFlow), chronic care (Somatus), and payer technology (HealthEdge, Humata Health, Belong Health), with an active jobs portal and a 21-person professional team led by President & Managing Director John Banta.
Economically, BVF operates as a private limited partnership and does not publicly disclose revenue, AUM, or fee economics. Capital is sourced exclusively from its Blue Plan LPs, and returns are generated through equity investments and liquidity events (IPOs, acquisitions). The fund's strategic positioning is reinforced by favorable regulatory tailwinds, including CMS Digital Mental Health Treatment reimbursement codes that directly benefit portfolio companies like Big Health. The model's principal constraint is structural: capital availability and distribution access are both functions of Blue Plan engagement, making LP relationship health the binding variable on growth.
The Blue Venture Fund firmographics
Firmographics- Name
- The Blue Venture Fund
- Legal name
- BlueCross BlueShield Venture Partners, L.P.
- Website
- https://www.blueventurefund.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The Blue Venture Fund is a healthcare-focused strategic venture capital platform owned and capitalized by 32 Blue Cross Blue Shield plans, investing from seed to buyout across healthcare technology, services, and clinical sciences while providing portfolio companies privileged distribution access to 115 million covered lives.
- Ownership category
- akta.pro rank
The Blue Venture Fund industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- All Other Financial Investment Activities (52399), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)
Keywords
Where The Blue Venture Fund is headquartered
LocationHeadquarters
- HQ city
- Chicago
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
The Blue Venture Fund business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Investment Returns: The Blue Venture Fund generates returns through equity investments in healthcare technology, services, and clinical sciences companies. Returns are realized through portfolio company exits including IPOs, acquisitions, and other liquidity events. The fund is owned, governed and capitalized by participating Blue Plans and affiliates.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
The Blue Venture Fund product offering
Product offeringCore offering
The Blue Venture Fund is a strategic venture capital partnership among participating Blue Cross Blue Shield companies, the Blue Cross Blue Shield Association, and Sandbox Industries. It invests capital in early-stage to growth-stage healthcare technology, healthcare services, and clinical sciences companies, while providing portfolio companies with direct access to 32 Blue Cross Blue Shield plans covering 115 million lives for commercialization support and payor contracting expertise.
Product overview
The Blue Venture Fund is a venture capital fund structured as a partnership among participating Blue Cross Blue Shield companies, the Blue Cross Blue Shield Association, and Sandbox Industries. Rather than offering a single unified product, the fund operates as an investment platform providing capital deployment, network access to 32 participating Blue Plans covering 115 million lives, and commercialization support through its BVF Platform. The platform connects portfolio companies to Blue Plan expertise through Advisory Groups and facilitates contracting relationships (270+ contracts). The fund focuses on three investment verticals: Healthcare Technology, Healthcare Services, and Clinical Sciences, with investments ranging from seed to growth to buyout stages.
Differentiator
Problem solved
Functional benefit
Products and services
- Blue Venture Fund Investment Platform A venture investment platform enabling Blue Cross Blue Shield companies to invest in healthcare technology, services, and clinical sciences companies. The platform connects portfolio companies with Blue Plan partners and provides commercialization support through the BVF platform.
- Healthcare Technology Investment Investment in companies building technology and services to improve the experience and operations of a health plan. Stage agnostic, from seed to growth to buyout.
- Healthcare Services Investment Investment in companies aiming to redesign the delivery of care and improve experiences with the healthcare system. Stage agnostic, from seed to growth to buyout.
- Clinical Sciences Investment Investment in companies that seek to improve medical care and decision-making. Stage agnostic, from seed to growth to buyout.
Quantifiable outcome
- 1 in 3 Americans covered by Blue Plans have access to innovations supported by BVF
- +2 more outcomes
Companies that use The Blue Venture Fund
Customer profileSegments3 records
Ideal customer profiles2 records
The Blue Venture Fund technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
The Blue Venture Fund partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Blue Cross Blue Shield AssociationcoreThe Blue Cross Blue Shield Association is a key partner in the Blue Venture Fund, providing governance and strategic direction for the fund's investment activities focused on healthcare innovation.
- Participating Blue Cross Blue Shield Companiescore32 Blue Cross Blue Shield companies and affiliates participate in the Blue Venture Fund, providing access to 115 million covered lives and 1,000+ network leaders. These plans collaborate on innovative healthcare solutions.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
The Blue Venture Fund competitors and assessment
Company assessmentDirect peers
- Echo Health Ventures: Echo Health Ventures is a strategic CVC formed by Cambia Health Solutions and Mosaic Health Solutions, both Blue Cross Blue Shield plans. It is a particularly close peer because it operates a similar payer-CVC model with BCBS-aligned plans, invests in healthcare technology and services, and offers portfolio companies distribution into multiple regional Blue-style plans.
- Optum Ventures: Optum Ventures is the corporate venture capital arm of UnitedHealth Group/Optum, investing in healthcare technology, services, and care delivery. It is the closest direct peer to BVF: a strategic CVC backed by a major US payer providing portfolio companies with distribution into a massive covered population, similar stage-agnostic mandate, and healthcare-only investment focus.
- Define Ventures: Define Ventures is a healthcare-focused venture capital firm investing in early-stage digital health, tech-enabled services, and consumer health companies. It is comparable to BVF in its healthcare-only investment thesis and emphasis on commercial value-add to portfolio companies, though it operates as a financial-return VC without the payer-owned strategic CVC structure.
- CVS Health Ventures: CVS Health Ventures is the CVC arm of CVS Health/Aetna, investing across healthcare technology, services, and consumer health. Like BVF, it is a payer-owned strategic fund providing portfolio companies with commercial access to a major US health plan and retail footprint; recent co-investor with BVF in Big Health's Series B.
Broad incumbents
- General Catalyst (Health Assurance): General Catalyst is a multi-stage VC with a dedicated Health Assurance thesis that invests in healthcare transformation, payer/provider technology, and care delivery. It is comparable to BVF in healthcare services and tech focus and has partnered with payers on go-to-market, though it is a financial-return firm rather than a payer-owned CVC.
- Bain Capital Life Sciences: Bain Capital Life Sciences is a dedicated healthcare and life sciences investment platform within Bain Capital, deploying venture and growth capital into clinical sciences, healthcare technology, and biotech. It is comparable to BVF in clinical sciences focus and stage-agnostic healthcare mandate, but operates as a generalist financial sponsor rather than a strategic CVC.
- New Mountain Capital (Healthcare): New Mountain Capital is a growth-oriented investment firm with a dedicated healthcare strategy covering payer services, value-based care, and healthcare technology. It overlaps with BVF in value-based care and payer-services investments (e.g., Somatus-like categories) but deploys buyout/growth capital rather than venture-stage checks.
- Andreessen Horowitz Bio + Health: a16z's Bio + Health fund invests across healthcare technology, digital health, and life sciences with a stage-agnostic approach. It is comparable to BVF's stage-agnostic healthcare investing model and similar deal sizes, though a16z operates as a financial-return generalist VC without the BCBS strategic distribution platform.
- KKR Health Care Strategic Growth: KKR's Health Care Strategic Growth strategy invests in growth-stage healthcare technology, services, and life sciences companies. It overlaps with BVF in healthcare services and clinical investment verticals, though it deploys larger growth equity checks and lacks the BCBS-payer distribution channel.
Emerging players
- Health2047: Health2047 is the strategic venture studio of the American Medical Association (AMA), investing in and building healthcare technology companies. It is thematically comparable to BVF as a strategic, mission-driven CVC in healthcare, though focused on physician-association distribution rather than payer-plan distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
The Blue Venture Fund social profiles
Digital presenceThe Blue Venture Fund financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Blue Venture Fund leadership team
Management profileNumber of profiles
Profiles12 records
The Blue Venture Fund funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Blue Venture Fund M&A and investment
M&A and investmentM&A
Investments118 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Blue Venture Fund
What does The Blue Venture Fund do?
The Blue Venture Fund is a strategic venture capital partnership among participating Blue Cross Blue Shield companies, the Blue Cross Blue Shield Association, and Sandbox Industries. It invests capital in early-stage to growth-stage healthcare technology, healthcare services, and clinical sciences companies, while providing portfolio companies with direct access to 32 Blue Cross Blue Shield plans covering 115 million lives for commercialization support and payor contracting expertise.
Is The Blue Venture Fund a public or private company?
The Blue Venture Fund is a private company. It is classified as corporate owned and is currently operating.
When was The Blue Venture Fund founded?
The Blue Venture Fund was founded in 2008. It employs 11 to 50 people.
Where is The Blue Venture Fund based?
The Blue Venture Fund is headquartered in Chicago, United States, in the North America region.
How does The Blue Venture Fund make money?
One revenue line is on record: investment Returns.
Who are The Blue Venture Fund's main competitors?
Direct peers on record are Echo Health Ventures, Optum Ventures, Define Ventures and CVS Health Ventures. Broad incumbents are General Catalyst (Health Assurance), Bain Capital Life Sciences, New Mountain Capital (Healthcare), Andreessen Horowitz Bio + Health and KKR Health Care Strategic Growth. Health2047 is listed as an emerging player.
Does The Blue Venture Fund have an API?
No public API is recorded for The Blue Venture Fund.
What industry is The Blue Venture Fund in?
The Blue Venture Fund's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms. Its NAICS code is 52399 and its SIC code is 6282.